angiex.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Sitemap: https://angiex.com/sitemap.xml User-agent: * Disallow: | ||
Meta Tags
| Title | Home - |
| Description | Exploiting novel biology to gain revolutionary power over Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to address the hallmarks of cancer |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 63.247.142.165 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
angiex.com Valuation
|
US$5,227,565
Last updated: 2023-05-08 10:20:10
angiex.com has Semrush global rank of 2,024,710. angiex.com has an estimated worth of US$ 5,227,565, based on its estimated Ads revenue. angiex.com receives approximately 603,181 unique visitors each day. Its web server is located in United States, with IP address 63.247.142.165. According to SiteAdvisor, angiex.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,227,565 |
| Daily Ads Revenue | US$4,826 |
| Monthly Ads Revenue | US$144,764 |
| Yearly Ads Revenue | US$1,737,161 |
| Daily Unique Visitors | 40,213 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| angiex.com. | A | 3599 | IP: 63.247.142.165 |
| angiex.com. | NS | 3600 | NS Record: ns2.perfecthealthdiet.com. |
| angiex.com. | NS | 3600 | NS Record: ns.perfecthealthdiet.com. |
| angiex.com. | MX | 3600 | MX Record: 10 mail.angiex.com. |
| angiex.com. | TXT | 3600 | TXT Record: v=spf1 +a +mx +ip4:63.247.139.180 +ip4:63.247.138.60 ~all |
HtmlToTextCheckTime:2023-05-08 10:20:10
| Menu About Science Pipeline Careers News Contact Exploiting novel biology to gain revolutionary power over cancer Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to address the hallmarks of cancer lethality Learn more ↓ Our vision No one should die of cancer Over one-third of people in developed countries develop cancer and 8.2 million people die from cancer every year. Angiex is committed to being part of the solution to the problem. Our latest findings Angiex, developer of Nuclear-Delivered Antibody- Drug Conjugate™ (ND-ADC) therapies for solid cancers, participated in the 13th Annual World ADC Meeting in San Diego, California. During the meeting, the company provided an overview of its technology and near-term plans for its lead asset, AGX101, in its poster “AGX101 – A novel TM4SF1-directed ADC for the treatment of all solid tumors.” Latest news ↓ Download poster Our Science Angiex’s Nuclear Delivery Platform™ delivers chemotherapeutic |
HTTP Headers
HTTP/1.1 200 OK Date: Fri, 29 Oct 2021 20:42:56 GMT Server: Apache Last-Modified: Mon, 18 Oct 2021 01:09:29 GMT Accept-Ranges: bytes Content-Length: 1431 Connection: close Content-Type: text/html |
angiex.com Whois Information
Domain Name: ANGIEX.COM Registry Domain ID: 1952923008_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-08-14T14:30:30Z Creation Date: 2015-08-13T21:52:13Z Registry Expiry Date: 2022-08-13T21:52:13Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS.PERFECTHEALTHDIET.COM Name Server: NS2.PERFECTHEALTHDIET.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T08:54:18Z <<< |